Fund Details
Sound Bioventures
Overview
Investment portfolio
13rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
AnaCardio | Sep 2026Participated | $71 MSeries B | |
Breye Therapeutics | Sep 2026Participated | $77 MSeries A | |
Cytospire Therapeutics | May 2026Participated | $83 MSeries A | |
BOOST Pharma | Nov 2025Led | $4 MOther Equity | |
ARTHEx Biotech | Sep 2025Participated | $87 MSeries B | |
AnaCardio | Jan 2025Led | $21 MSeries A | |
Artax Biopharma | Aug 2024Participated | $8 MOther Equity | |
Theolytics | Apr 2024Participated | $24 MOther Equity | |
AbolerIS Pharma | Sep 2023Participated | $29 MSeries A | |
VarmX | May 2023Led | $32 MSeries B | |
Teitur Trophics | Mar 2023Led | $30 MSeries A | |
Breye Therapeutics | Nov 2022Led | $4 MSeed | |
AnaCardio | Sep 2026Participated | $71 MSeries B | |
Breye Therapeutics | Sep 2026Participated | $77 MSeries A | |
Cytospire Therapeutics | May 2026Participated | $83 MSeries A | |
BOOST Pharma | Nov 2025Led | $4 MOther Equity | |
ARTHEx Biotech | Sep 2025Participated | $87 MSeries B | |
AnaCardio | Jan 2025Led | $21 MSeries A | |
Artax Biopharma | Aug 2024Participated | $8 MOther Equity | |
Theolytics | Apr 2024Participated | $24 MOther Equity | |
AbolerIS Pharma | Sep 2023Participated | $29 MSeries A | |
VarmX | May 2023Led | $32 MSeries B | |
Teitur Trophics | Mar 2023Led | $30 MSeries A | |
Breye Therapeutics | Nov 2022Led | $4 MSeed |
13 Items
13
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 0 |
| Series A | 2 | 3 |
| Series B | 1 | 2 |
| Other Equity | 2 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| May '22 | 1 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 1 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 1 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 1 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 1 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 2 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 13 |
| Manufacturing | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 2 |
| $5M-$10M | 1 |
| $10M-$25M | 2 |
| $25M-$50M | 4 |
| $50M-$100M | 4 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 11 |
| United States | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Novo Holdings | 4 |
| Columbus Venture Partners | 3 |
| Industrifonden | 3 |
| Innovestor | 3 |
| Advent Life Sciences | 2 |
| Eli Lilly and Company | 2 |
| European Innovation Council | 2 |
| Flerie Invest | 2 |
| Ljungstrom family office | 2 |
| Modi Ventures | 2 |
| Pureos Bioventures | 2 |
| 4BIO Capital | 1 |
| Abingworth | 1 |
| Advent France Biotechnology | 1 |
| BioGeneration Ventures | 1 |
| BioInnovation Institute | 1 |
| BioVentures Investors | 1 |
| Bpifrance | 1 |
| British Business Bank | 1 |
| Caixa Capital Risc | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 6 | 46% |
| Participating | 7 | 54% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 33% |
| Co-led | 4 | 67% |
Team
Johan Kördel
Managing Partner